Form D · Pharmaceuticals
Madrigal Pharmaceuticals, Inc.
Fort Washington, PA · CIK 0001673226
Offering snapshot reported Apr 28, 2016 · SEC filing
- Reported sold
- $3.38M Offering amount: $9M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 13, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2016 | Initial | $3,375,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-262200
Source: Form D, filed Apr 28, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lionel Carnot | Director |
| Fred Craves | Director |
| Rebecca Taub | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
500 Office Center Drive Suite 400
Fort Washington, PA, 19034
Fort Washington, PA, 19034